Generic placeholder image

Current Cardiology Reviews

Editor-in-Chief

ISSN (Print): 1573-403X
ISSN (Online): 1875-6557

Review Article

Part 1: The Wider Considerations in Translating Heart Failure Guidelines

Author(s): Pupalan Iyngkaran*, Andrew Wilson, James Wong, David Prior, David Kaye, David L Hare, Peter Bergin and Michael Jelinem

Volume 17 , Issue 5 , 2021

Published on: 08 January, 2021

Article ID: e160721190003 Pages: 9

DOI: 10.2174/1573403X16666210108104945

Price: $65

Abstract

Congestive Heart Failure (CHF) is an emerging epidemic. Within one generation, the medical community has learned much of CHF syndromes. It has two distinct mechanisms, systolic and diastolic abnormalities, to account for the common CHF presentation. It is complex as it challenges the available health care services, resource, and funding models in providing an equitable service across the health continuum. Despite the improvement in many cardiovascular diseases, some CHF outcomes like readmissions and costs have increased. The reinvigoration of evidence- based medicine, the development of health services models of care, and standardisation of disease processes with taxonomies have also occurred within the same time span. These processes, however, need to be linked with health policy as presented in white papers. In this paper, we explore achieving optimal CHF guideline-recommended outcomes as the science approaches realworld translation.

Keywords: Congestive heart failure, cost-efficacy, health services, taxonomy, white-papers, health systems.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy